Anti-coagulation assessment with prothrombin time and anti-Xa assays in real-world patients on treatment with rivaroxaban
Crossref DOI link: https://doi.org/10.1007/s00277-015-2407-y
Published Online: 2015-05-30
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Königsbrügge, Oliver
Quehenberger, Peter
Belik, Sabine
Weigel, Günter
Seger, Christoph
Griesmacher, Andrea
Pabinger, Ingrid
Ay, Cihan
Text and Data Mining valid from 2015-05-30